You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
Features & Benefits
-
Singular Placement
- Allows electrode placement in both coronary sinus and right atrium for simultaneous electrogram reading
- Requires fewer diagnostic catheters for atrial fibrillation* and flutter† procedures
- Easy positioning, stability in varying anatomies, and reliable signal reference
References
*THERMOCOOL® Navigation Catheters are approved for drug-refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with CARTO® Systems (excluding NAVISTAR® RMT THERMOCOOL® Catheter).
†In the U.S., THERMOCOOL® non-navigational Catheters are indicated for the treatment of Type 1 Atrial Flutter in patients 18 years of age or older.
105368-201117
Last Updated on 6/29/2020
This site is published by Biosense Webster, Inc. which is solely responsible for its contents. It is intended for visitors from the United States.